Literature DB >> 21987091

ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease.

Y Onouchi1, Y Suzuki, H Suzuki, M Terai, K Yasukawa, H Hamada, T Suenaga, T Honda, A Honda, H Kobayashi, T Takeuchi, N Yoshikawa, J Sato, S Shibuta, M Miyawaki, K Oishi, H Yamaga, N Aoyagi, S Iwahashi, R Miyashita, Y Murata, R Ebata, K Higashi, K Ozaki, K Sasago, T Tanaka, A Hata.   

Abstract

Functional single-nucleotide polymorphisms (SNPs) in inositol 1,4,5-trisphosphate 3-kinase C (ITPKC) (rs28493229) and caspase-3 (CASP3) (rs113420705; formerly rs72689236) are associated with susceptibility to Kawasaki's disease (KD). To evaluate the involvement of these 2 SNPs in the risk for intravenous immunoglobulin (IVIG) unresponsiveness, we investigated 204 Japanese KD patients who received a single IVIG dose of 2 g kg(-1) (n=70) or 1 g kg(-1) daily for 2 days (n=134). The susceptibility allele of both SNPs showed a trend of overrepresentation in IVIG non-responders and, in combined analysis of these SNPs, patients with at least 1 susceptible allele at both loci had a higher risk for IVIG unresponsiveness (P=0.0014). In 335 prospectively collected KD patients who were treated with IVIG (2 g kg(-1)), this 2-locus model showed a more significant association with resistance to initial and additional IVIG (P=0.011) compared with individual SNPs. We observed a significant association when all KD patients with coronary artery lesions were analyzed with the 2-locus model (P=0.0031). Our findings strongly suggest the existence of genetic factors affecting patients' responses to treatment and the risk for cardiac complications, and provide clues toward understanding the pathophysiology of KD inflammation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21987091     DOI: 10.1038/tpj.2011.45

Source DB:  PubMed          Journal:  Pharmacogenomics J        ISSN: 1470-269X            Impact factor:   3.550


  45 in total

1.  A genome-wide association study identifies three new risk loci for Kawasaki disease.

Authors:  Yoshihiro Onouchi; Kouichi Ozaki; Jane C Burns; Chisato Shimizu; Masaru Terai; Hiromichi Hamada; Takafumi Honda; Hiroyuki Suzuki; Tomohiro Suenaga; Takashi Takeuchi; Norishige Yoshikawa; Yoichi Suzuki; Kumi Yasukawa; Ryota Ebata; Kouji Higashi; Tsutomu Saji; Yasushi Kemmotsu; Shinichi Takatsuki; Kazunobu Ouchi; Fumio Kishi; Tetsushi Yoshikawa; Toshiro Nagai; Kunihiro Hamamoto; Yoshitake Sato; Akihito Honda; Hironobu Kobayashi; Junichi Sato; Shoichi Shibuta; Masakazu Miyawaki; Ko Oishi; Hironobu Yamaga; Noriyuki Aoyagi; Seiji Iwahashi; Ritsuko Miyashita; Yuji Murata; Kumiko Sasago; Atsushi Takahashi; Naoyuki Kamatani; Michiaki Kubo; Tatsuhiko Tsunoda; Akira Hata; Yusuke Nakamura; Toshihiro Tanaka
Journal:  Nat Genet       Date:  2012-03-25       Impact factor: 38.330

Review 2.  Kawasaki disease: insights into pathogenesis and approaches to treatment.

Authors:  Stanford T Shulman; Anne H Rowley
Journal:  Nat Rev Rheumatol       Date:  2015-04-28       Impact factor: 20.543

3.  Identification of Differentially Expressed Genes in Kawasaki Disease Patients as Potential Biomarkers for IVIG Sensitivity by Bioinformatics Analysis.

Authors:  Lan He; Youyu Sheng; Chunyun Huang; Guoying Huang
Journal:  Pediatr Cardiol       Date:  2016-05-09       Impact factor: 1.655

4.  Meta-analysis of the relationship between single nucleotide polymorphism rs72689236 of caspase-3 and Kawasaki disease.

Authors:  Yanlin Xing; Hong Wang; Xiaomei Liu; Xianyi Yu; Rui Chen; Ce Wang; Xuexin Yu; Le Sun
Journal:  Mol Biol Rep       Date:  2014-07-03       Impact factor: 2.316

5.  Distribution of Kawasaki Disease Coronary Artery Aneurysms and the Relationship to Coronary Artery Diameter.

Authors:  Etsuko Tsuda; Nobuyuki Tsujii; Kohji Kimura; Atsuko Suzuki
Journal:  Pediatr Cardiol       Date:  2017-03-20       Impact factor: 1.655

6.  Calcineurin inhibitor treatment of intravenous immunoglobulin-resistant Kawasaki disease.

Authors:  Adriana H Tremoulet; Paige Pancoast; Alessandra Franco; Matthew Bujold; Chisato Shimizu; Yoshihiro Onouchi; Alyson Tamamoto; Guliz Erdem; Debra Dodd; Jane C Burns
Journal:  J Pediatr       Date:  2012-04-06       Impact factor: 4.406

7.  Combined analysis of genome-wide-linked susceptibility loci to Kawasaki disease in Han Chinese.

Authors:  Yuanlong Yan; Yongyi Ma; Yunqiang Liu; Hongde Hu; Ying Shen; Sizhong Zhang; Yongxing Ma; Dachang Tao; Qing Wu; Qian Peng; Yuan Yang
Journal:  Hum Genet       Date:  2013-03-01       Impact factor: 4.132

8.  A functional polymorphism, rs28493229, in ITPKC and risk of Kawasaki disease: an integrated meta-analysis.

Authors:  Jiao Lou; Sanqing Xu; Li Zou; Rong Zhong; Ti Zhang; Yu Sun; Xuzai Lu; Li Liu; Chuanqi Li; Li Wang; Guanglian Xiong; Wei Wang; Fangqi Gong; Jing Wu
Journal:  Mol Biol Rep       Date:  2012-10-13       Impact factor: 2.316

9.  One Size Does Not Fit All: Genetic Prediction of Kawasaki Disease Treatment Response in Diverse Populations.

Authors:  Michael A Portman; Sadeep Shrestha
Journal:  Circ Cardiovasc Genet       Date:  2017-10

10.  Predictive model based on gene and laboratory data for intravenous immunoglobulin resistance in Kawasaki disease in a Chinese population.

Authors:  Li Meng; Zhen Zhen; Xiao-Hui Li; Yue Yuan; Qian Jiang; Wei Yao; Ming-Ming Zhang; Ai-Jie Li; Lin Shi
Journal:  Pediatr Rheumatol Online J       Date:  2021-06-26       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.